Page last updated: 2024-11-05

3-bromopropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

3-Bromopropionic acid is a haloalkanoic acid with the molecular formula C3H5BrO2. It is a colorless liquid with a pungent odor. It is used as an intermediate in the synthesis of various organic compounds, such as pharmaceuticals and pesticides. 3-bromopropionic acid is also used as a reagent in the synthesis of polymers and resins. It is studied for its potential applications in various fields, including medicine and agriculture. The compound is synthesized through a variety of methods, including the reaction of propionic acid with bromine in the presence of a catalyst. 3-bromopropionic acid is a corrosive substance and can cause irritation to the skin, eyes, and respiratory system. It is also considered to be a potential environmental hazard due to its toxicity to aquatic life. However, further research is needed to fully understand its environmental impact.'

Cross-References

ID SourceID
PubMed CID11553
CHEMBL ID4569339
SCHEMBL ID28472
MeSH IDM0109403

Synonyms (47)

Synonym
unii-wfz7csr69r
wfz7csr69r ,
EN300-20490
propanoic acid, 3-bromo-
.beta.-bromopropionic acid
nsc-2638
nsc2638
wln: qv2e
2-carboxyethyl bromide
590-92-1
3-bromopropionic acid
3-bromopropanoic acid
propionic acid, 3-bromo-
hsdb 5496
ai3-18966
beta-bromopropanoic acid
brn 1071333
beta-bromopropionic acid
einecs 209-694-1
nsc 2638
inchi=1/c3h5bro2/c4-2-1-3(5)6/h1-2h2,(h,5,6
3-bromopropionic acid, 97%
B0645
3-bromo-propionic acid
AKOS005111073
FT-0653176
|a-bromopropionic acid
STL282736
FT-0615241
AM20100434
SCHEMBL28472
.beta.-bromopropanoic acid
propionic acid, .beta.-bromo-
.beta.-bromopropionic acid [mi]
DTXSID9060443
br(ch2)2co2h
3- bromopropionic acid
W-105346
F2191-0199
mfcd00002763
Q22133309
3-bromopropionic--d4 acid
STR00360
P17146
CHEMBL4569339
SB40497
BP-31254
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1605095Inhibition of N-terminal His6-sumo-tagged full length Staphylococcus aureus ClpP expressed in Escherichia coli BL2 (DE3) at 10 uM pre-incubated for 10 mins before Suc-LY-AMC addition and measured after 1 hr by fluorescence based assay relative to control2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's3 (27.27)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.19 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index53.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]